Chugai Pharmaceutical Co., Ltd. (CHGCF) Q3 2024 Earnings Call Transcript [Seeking Alpha]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Seeking Alpha
149.62K Follower s Follow Play Earnings Call Chugai Pharmaceutical Co., Ltd. ( OTCPK:CHGCF ) Q3 2024 Earnings Conference Call October 25, 2024 5:00 AM ET Company Participants Kae Miyata - Corporate Communications Department Osamu Okuda - President and CEO Tsukasa Kusano - Executive Vice President, Head, Project and Lifecycle Management Unit Iwaaki Taniguchi - Chief Financial Officer Junichi Takano - Head, Marketing and Sales Division Conference Call Participants Seiji Wakao - JPMorgan Hidemaru Yamaguchi - Citigroup Securities Shinichiro Muraoka - Morgan Stanley MUFG Securities Tony Ren - Macquarie Capital Hiroshi Wada - SMBC Nikko Securities Kazuaki Hashiguchi - Daiwa Securities Kasumi Haruta - UBS Securities Kae Miyata Thank you for joining Chugai Pharmaceutical's Earnings Call on the Financial Results for the Fiscal Year 2024 Third Quarter. I am Miyata from Corporate Communications Department. I would like to serve as your moderator today. To
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Roche presents new data at CTAD, demonstrating its growing momentum in diagnostics for Alzheimer's disease [Yahoo! Finance]Yahoo! Finance
- New England Journal of Medicine Publishes Landmark Phase III Results for Genentech’s Itovebi, Showing More Than Doubling of Progression-Free Survival in Certain Type of HR-Positive Advanced Breast CancerBusiness Wire
- Neuvivo Expands Board of Directors in Preparation of Upcoming NDA Review with the Appointment of Robert Baffi, PhD, MBA [Yahoo! Finance]Yahoo! Finance
- Chugai Pharmaceutical Co., Ltd. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]Seeking Alpha
- Dyno and Roche collaborate on neurological gene therapies [Yahoo! Finance]Yahoo! Finance